Evidence map›Paper›PMID 31881298›Full record

ArticleJournal of the American Academy of Dermatology2020

Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease.

Jalal Maghfour, Erika Elliott, Frances Gill, Brittany Stumpf, Andrea Murina

Open access · greenAbstract readLetter
In one paragraph

Article in Journal of the American Academy of Dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ixekizumab May Improve Renal Function in Psoriasis.Healthcare (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jalal MaghfourTulane University School of Medicine, Department of Dermatology, New Orleans, Louisiana.
Erika ElliottTulane University School of Medicine, Department of Dermatology, New Orleans, Louisiana.
Frances GillTulane University School of Medicine, Department of Dermatology, New Orleans, Louisiana.
Brittany StumpfTulane University School of Medicine, Department of Dermatology, New Orleans, Louisiana.
Andrea MurinaTulane University School of Medicine, Department of Dermatology, New Orleans, Louisiana. Electronic address: amurina@tulane.edu.
Tulane University · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedBiological ProductsDisease ProgressionFemaleGlomerular Filtration RateHumansMaleMiddle AgedPsoriasisRenal Insufficiency, ChronicRetrospective StudiesTreatment OutcomeBiological Products

Identifiers

PMID31881298
PMCPMC7446959
OpenAlexW2998175073

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.